CY1116523T1 - PHOSPHONE NUCLEOTIDE ANALYSIS PRODUCTS AND METHODS FOR SELECTION AND MANUFACTURE - Google Patents
PHOSPHONE NUCLEOTIDE ANALYSIS PRODUCTS AND METHODS FOR SELECTION AND MANUFACTUREInfo
- Publication number
- CY1116523T1 CY1116523T1 CY20151100413T CY151100413T CY1116523T1 CY 1116523 T1 CY1116523 T1 CY 1116523T1 CY 20151100413 T CY20151100413 T CY 20151100413T CY 151100413 T CY151100413 T CY 151100413T CY 1116523 T1 CY1116523 T1 CY 1116523T1
- Authority
- CY
- Cyprus
- Prior art keywords
- novel
- compounds
- phosphone
- selection
- manufacture
- Prior art date
Links
Abstract
Παρέχεται νέα μέθοδος για συστηματική εξέταση προφαρμάκων αναλόγων μεθοξυφωσφονικού νουκλεοτιδίου για να πιστοποιούνται προφάρμακα που στοχεύουν εκλεκτικώς επιθυμητούς ιστούς με αντι-ιική ή κατά του όγκου δραστικότητα. Η μέθοδος αυτή έχει οδηγήσει στην πιστοποίηση νέων δεικτών εστέρα-αμιδικών του ΡΜΡΑ για ρετροϊική ή ηπατοτροφικής-dna μόλυνσης θεραπεία, συμπεριλαμβανομένων ενώσεων της σύνταξης (5a) που έχουν ομάδες υποκαταστάτη όπως ορίζεται στο παρόν. Παρέχονται συνθέσεις αυτών των νέων ενώσεων σε φαρμακευτικώς αποδεκτά έκδοχα και χρήση αυτών στην θεραπεία και προφύλαξη. Επίσης, παρέχεται βελτιωμένη μέθοδος για την χρήση αλκοξειδίου μαγνησίου για την παρασκευή υλικών έναρξης και ενώσεων για χρήση στο παρόν.A novel method is provided for screening prodrug analogs of methoxyphosphonate nucleotide to identify prodrugs that target selectively desirable tissues with antiviral or antitumor activity. This method has led to the identification of novel PMPA ester-amide markers for retroviral or hepatotrophic-dna infection treatment, including compounds of the structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided. Also provided is an improved method for the use of magnesium alkoxide for the preparation of starting materials and compounds for use herein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22002100A | 2000-07-21 | 2000-07-21 | |
EP01961695.2A EP1301519B2 (en) | 2000-07-21 | 2001-07-20 | Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1116523T1 true CY1116523T1 (en) | 2016-12-14 |
Family
ID=58464055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100413T CY1116523T1 (en) | 2000-07-21 | 2015-05-11 | PHOSPHONE NUCLEOTIDE ANALYSIS PRODUCTS AND METHODS FOR SELECTION AND MANUFACTURE |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1116523T1 (en) |
-
2015
- 2015-05-11 CY CY20151100413T patent/CY1116523T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119411T1 (en) | PHOSPHONE NUCLEOTIDE ANALYSIS PRODUCTS AND METHODS FOR SELECTION AND MANUFACTURE | |
CY1116876T1 (en) | Oligonucleotide analogs incorporating 5-aza-cytosine in them | |
ES2118069T3 (en) | PHOSPHONATE DRUGS. | |
CY1106207T1 (en) | ANTIINIC NUCLEOSITE DERIVATIVES | |
CY1116929T1 (en) | Pyrrolo [2,3-D] Pyrimidine Derivatives as Protein Kinase Inhibitors B | |
PT1309589E (en) | COMPOUNDS OF UREA AND METHODS OF UTILIZATION | |
MX2009012433A (en) | Azido purine nucleosides for treatment of viral infections. | |
CY1107894T1 (en) | GABA analogue prodrugs, their compositions and uses | |
CY1107626T1 (en) | PYRAZOLI PRODUCTS FOR HIV TREATMENT | |
UY26782A1 (en) | DERIVATIVES OF BENZOTIAZOLE | |
CY1113647T1 (en) | CARBON-NUCLEOSIDI ANALOGS FOR ANTI-VIRTUAL TREATMENT | |
CY1108355T1 (en) | COMPOSITIONS AND METHODS FOR COMBINATIVE ANTI-TREATMENT | |
AR022860A1 (en) | CAMPTOTECHINE DERIVATIVES THAT HAVE ANTITUMORAL ACTIVITY | |
CY1113354T1 (en) | PHOSPHORYLASES AND NUCLEOZIDE NUCLEARIDE INHIBITIONS | |
ATE453636T1 (en) | SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE | |
DK1914237T3 (en) | Antiviral phosphonate ester compounds | |
EA200701406A1 (en) | ACCESSIBLE FOR THE TREATMENT OF HIV COMPOUNDS | |
ECSP066730A (en) | COMPOUNDS AND PROCEDURES FOR USE | |
CY1112962T1 (en) | 1,2-BILZENIMIDAZOLES FOR DISEASE TREATMENT, BASED ON MICROGLOBE ACTIVATION | |
CY1110005T1 (en) | GRANZYM B AS A DISTRIBUTOR OF CELL TUMORS DEPENDENT ON A HSP70 / HSP70 Peptide | |
ES2151716T3 (en) | PEPTIDED DERIVATIVES. | |
CY1116523T1 (en) | PHOSPHONE NUCLEOTIDE ANALYSIS PRODUCTS AND METHODS FOR SELECTION AND MANUFACTURE | |
AR101679A2 (en) | COMPOSITIONS FOR COMBINED ANTIVIRAL TREATMENT | |
CY1116248T1 (en) | IMMUNE OLIGORIBONUCLEOTIDES | |
UY27330A1 (en) | HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS. |